OXGENE helps pioneering companies accelerate the discovery and biomanufacture of their CAR-T / Cell Therapies and Gene Therapies, to be first to deliver these breakthrough therapeutics to the patients who need them.
- Investment status Realised
- Invested 2013
- Category Health & Life Sciences